| Pedro P Jakos, MD | |
|
379 N Congress Ave, Boynton Beach, FL 33426-3415 | |
| (561) 336-0191 | |
| (561) 364-7785 |
| Full Name | Pedro P Jakos |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 379 N Congress Ave, Boynton Beach, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952390775 | NPI | - | NPPES |
| 269054300 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | ME89345 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pedro P Jakos, MD 900 S Pine Island Rd, Ste 800, Plantation, FL 33324-3920 Ph: (561) 336-0191 | Pedro P Jakos, MD 379 N Congress Ave, Boynton Beach, FL 33426-3415 Ph: (561) 336-0191 |
News Archive
University of Adelaide researchers have uncovered the role played by a gene which suppresses the development of cancer. The findings, published in the journal PLOS ONE, open new opportunities for scientists to find treatments for cancer.
According to the research abstract published recently in an online supplement of Sleep, social jet lag has emerged as an important circadian marker for health outcomes.
The holiday season is synonymous with joy, family and sharing, but it can also mean anxiety, melancholy and illness. With the recent economic downturn and the H1N1 pandemic, many Canadians are facing higher stress levels, sleepless nights and health problems.
Melinda Gates today urged global leaders to make women's and children's health a top priority, and announced that the Gates Foundation will invest $1.5 billion over the next five years to support maternal and child health, family planning, and nutrition programs in developing countries.
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.
› Verified 6 days ago
Mrs. Deborah R. Nuessly, ARNP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6080 Boynton Beach Blvd Ste 240, Boynton Beach, FL 33437 Phone: 561-509-5009 Fax: 561-738-0556 | |
Dr. Jean S Pierre, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 Quantum Blvd, Boynton Beach, FL 33426 Phone: 561-740-7514 Fax: 844-530-0155 | |
Dr. Allen Wendt, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 10301 Hagen Ranch Rd, Bldg A, Suite 760, Boynton Beach, FL 33437 Phone: 561-733-4400 Fax: 561-733-5004 | |
Ilene Joy Goldstein, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 10301 Hagen Ranch Rd Ste 760, Boynton Beach, FL 33437 Phone: 954-315-5750 Fax: 954-733-5004 | |
Peter Oppenheimer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 379 N Congress Ave, Boynton Beach, FL 33426 Phone: 561-336-0191 Fax: 561-364-7785 | |
Dr. Judith Cornely, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2828 S Seacrest Blvd, Suite 214, Boynton Beach, FL 33435 Phone: 561-734-1888 Fax: 561-734-8274 | |
Nitha Ann Yoyakey, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 379 N Congress Ave, Boynton Beach, FL 33426 Phone: 561-336-0191 Fax: 561-364-7785 |